Getting The Deal Through logo
Getting The Deal Through


EMA’s halt on harmonisation and regulatory efforts raises “significant concern” lawyers say

Pharma - News – 07 August 2018

Life sciences lawyers in Europe have warned that the European Medicines Agency’s decision to scale back its international regulatory harmonisation efforts in the run up to Brexit risks complicating the drug approval process and diminishing the agency’s role in global cooperation efforts.


Morgan Lewis scoops seven-partner IP team from McDermott

Pharma - News – 07 August 2018

Morgan Lewis Bockius has added a seven-partner life sciences litigation team formerly of McDermott Will & Emery across its Chicago, Washington, DC, San Francisco and Silicon Valley offices.


DOJ probes AstraZeneca bribery allegations

Pharma - News – 07 August 2018

The US Department of Justice has opened an investigation into allegations that Anglo-Swedish pharmaceutical company AstraZeneca and several other healthcare businesses bribed Iraqi officials and inadvertently funded terrorist attacks.


Allergan says Pfizer should cover damages in multidistrict opioid suit

Pharma - News – 07 August 2018

The US arm of global pharma company Allergan has filed a third-party complaint in multidistrict litigation proceedings in Ohio relating to the US opioid crisis, claiming Pfizer should indemnify it for any liability from the prescription of painkiller Kadian.


The PLN Round-up (7 August)

Pharma - The Round-up – 07 August 2018

News in brief from around the world… Actor Clint Eastwood has been in court in the US alleging unlawful use of drug patents while a Belgian consumer group has filed a complaint with the country’s regulator over alleged inaction in the face of a contamination scare.  


Community round-up: US firms boost their life sciences teams

Pharma - News – 31 July 2018

Greenberg Traurig, Ropes & Gray and Cantor Colburn have all announced high-profile hires in recent weeks, while biologics developer MiMedx has appointed a new chief compliance officer.






Follow Getting the Deal Through for the latest updates on law and regulation worldwide

Follow us on LinkedIn